Oncology-Inspired Treatment Options for COVID-19

CR3022 is a human antibody that binds to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we explore the use of CR3022 as a molecularly targeted radiotherapeutic. Methods: CR3022 was labeled with (131)I and purified, yielding (131)I-CR3022. Using a magnetic bead assay and a recomb...

Descripción completa

Detalles Bibliográficos
Autores principales: Pillarsetty, Nagavarakishore, Carter, Lukas M., Lewis, Jason S., Reiner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2020
Materias:
COVID Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679628/
https://www.ncbi.nlm.nih.gov/pubmed/32680924
http://dx.doi.org/10.2967/jnumed.120.249748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679628/
https://www.ncbi.nlm.nih.gov/pubmed/32680924
http://dx.doi.org/10.2967/jnumed.120.249748

Ejemplares similares